peptide-research-suppliers Tethered macrocyclic peptides (MCPs) represent a promising and structurally distinct class of antibiotics that are emerging as crucial weapons against highly resistant bacteria2024年3月21日—It is classified under a new antibiotic class of drugs calledtethered macrocyclic peptides. Zosurabalpin targets the lipopolysaccharide .... These novel compounds, exemplified by the antibiotic Zosurabalpin, are engineered with unique mechanisms of action, offering hope in the face of escalating antimicrobial resistance.作者：Q Weng·2024·被引用次数：9—Zosurabalpin: a noveltethered macrocyclic peptideantibiotic that kills carbapenem-resistant Acinetobacter baumannii. Their development marks a significant advancement in drug discovery, particularly for combating challenging Gram-negative infections like carbapenem-resistant *Acinetobacter baumannii* (CRAB).
The increasing threat of antibiotic-resistant pathogens necessitates the discovery of new antibacterial agents with novel modes of actionNew class of antibiotics is a welcome discovery. Traditional antibiotics often struggle against complex Gram-negative bacteria due to their formidable outer membrane and efflux pumps. Tethered macrocyclic peptides have emerged as a solution by leveraging unique structural features and targeting essential bacterial processes. The "tethered" aspect refers to a specific molecular arrangement within these peptides, which allows them to interact with bacterial targets in a differentiated manner compared to conventional macrocyclic peptides. This structural innovation is key to their potent activity against otherwise intractable infections.
Zosurabalpin stands as a prime example of the potential of tethered macrocyclic peptides. This novel antibiotic has demonstrated significant efficacy against carbapenem-resistant *Acinetobacter baumannii* (CRAB), a pathogen notorious for its multi-drug resistance and high mortality rates. Zosurabalpin's mechanism of action involves inhibiting the transport of lipopolysaccharide (LPS) across the bacterial membrane. LPS is a critical component of the Gram-negative bacterial cell envelope, and its disrupted transport compromises bacterial integrity, leading to cell death作者：Q Weng·2024·被引用次数：9—Zosurabalpin: a noveltethered macrocyclic peptideantibiotic that kills carbapenem-resistant Acinetobacter baumannii.. This targeted disruption of a fundamental bacterial process offers a unique advantage over antibiotics that rely on more commonly targeted pathways, making resistance development more challenging for bacteria.
The distinct structural class of tethered macrocyclic peptides confers several advantages2024年3月21日—It is classified under a new antibiotic class of drugs calledtethered macrocyclic peptides. Zosurabalpin targets the lipopolysaccharide .... Their larger molecular weights, compared to many traditional antibiotics, can influence their pharmacokinetic properties and target interactions作者：H Peacock·2021·被引用次数：63—Figure 3: Ribosomally-synthesizedmacrocyclic peptideswith exotic structures. Color coding: green = nonproteinogenic residues, blue = cyclizationtether. CCDC.. The tethering strategy allows for precise positioning of functional groups, enhancing binding affinity and specificity to bacterial targets. Furthermore, the development of these peptides often involves sophisticated screening and synthetic methodologies, enabling the generation of vast libraries of unique compounds with tailored properties.作者：G Kumar·2025·被引用次数：6—Tethered macrocyclic peptide(MCP). Zampaloni et al. carried out screenings of macrocyclic peptides of Tranzyme Pharma. From the initial ... This approach has been instrumental in identifying molecules like Zosurabalpin that possess potent antibacterial activity through novel pathways.
The emergence of tethered macrocyclic peptides is particularly significant in the context of antimicrobial resistance (AMR). CRAB, for instance, poses a severe global health threat, and treatment options are severely limited. Compounds like Zosurabalpin offer a much-needed therapeutic avenue by exhibiting activity against strains that are resistant to nearly all existing antibiotics. The differentiated mode of action means that bacteria are less likely to possess pre-existing resistance mechanisms against these novel agentsZosurabalpin, a novel tethered macrocyclic peptide antibiotic, exhibits potent activity against Acinetobacter spp., particularly carbapenem-resistant .... This makes tethered macrocyclic peptides a critical component of future strategies to combat AMR and preserve the effectiveness of antibiotics.
While the discovery of tethered macrocyclic peptides like Zosurabalpin is highly encouraging, challenges remain. Further research is needed to optimize their pharmacokinetic profiles, assess their safety and tolerability in clinical settings, and explore their potential against a broader spectrum of resistant pathogens. The complexity of their synthesis and manufacturing could also present hurdles to widespread accessibility. However, the fundamental breakthrough in designing molecules with novel mechanisms of action underscores the immense potential of tethered macrocyclic peptides to redefine the landscape of antibiotic therapy and provide effective solutions against the most daunting bacterial threats.The search for new antibiotics goes macrocyclic
Join the newsletter to receive news, updates, new products and freebies in your inbox.